A detailed history of Capital Insight Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Insight Partners, LLC holds 86,582 shares of PFE stock, worth $2.4 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
86,582
Previous 89,162 2.89%
Holding current value
$2.4 Million
Previous $2.57 Million 6.39%
% of portfolio
0.45%
Previous 0.53%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$25.89 - $29.73 $66,796 - $76,703
-2,580 Reduced 2.89%
86,582 $2.4 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $23,595 - $30,647
903 Added 1.02%
89,162 $2.57 Million
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $82,663 - $96,625
2,576 Added 3.01%
88,259 $2.93 Million
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $1,480 - $1,713
-41 Reduced 0.05%
85,683 $3.14 Million
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $144,009 - $187,479
3,656 Added 4.45%
85,724 $3.5 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $294,838 - $384,879
7,062 Added 9.42%
82,068 $4.21 Million
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $46,341 - $56,571
1,059 Added 1.43%
75,006 $3.28 Million
Q2 2022

Jul 20, 2022

BUY
$46.53 - $55.17 $54,719 - $64,879
1,176 Added 1.62%
73,947 $3.88 Million
Q1 2022

Apr 21, 2022

SELL
$45.75 - $56.69 $138,348 - $171,430
-3,024 Reduced 3.99%
72,771 $3.77 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $17,767 - $26,337
430 Added 0.57%
75,795 $4.48 Million
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $38,072 - $48,907
970 Added 1.3%
75,365 $3.24 Million
Q2 2021

Aug 02, 2021

BUY
$35.91 - $40.68 $88,374 - $100,113
2,461 Added 3.42%
74,395 $2.91 Million
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $682,593 - $769,828
20,382 Added 39.54%
71,934 $2.61 Million
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $14,124 - $17,960
422 Added 0.83%
51,552 $1.9 Million
Q3 2020

Nov 04, 2020

BUY
$31.75 - $37.25 $13,589 - $15,943
428 Added 0.84%
51,130 $1.88 Million
Q2 2020

Jul 15, 2020

BUY
$30.12 - $36.54 $77,709 - $94,273
2,580 Added 5.36%
50,702 $1.66 Million
Q1 2020

Apr 14, 2020

BUY
$27.03 - $38.62 $76,359 - $109,101
2,825 Added 6.24%
48,122 $1.57 Million
Q4 2019

Jan 27, 2020

SELL
$32.92 - $37.36 $18,929 - $21,482
-575 Reduced 1.25%
45,297 $1.78 Million
Q3 2019

Oct 09, 2019

BUY
$32.49 - $42.13 $2,436 - $3,159
75 Added 0.16%
45,872 $1.65 Million
Q2 2019

Jul 09, 2019

SELL
$36.98 - $41.52 $13,608 - $15,279
-368 Reduced 0.8%
45,797 $1.98 Million
Q1 2019

Apr 04, 2019

SELL
$37.5 - $41.2 $52,462 - $57,638
-1,399 Reduced 2.94%
46,165 $1.96 Million
Q4 2018

Jan 03, 2019

BUY
$38.47 - $43.86 $1,538 - $1,754
40 Added 0.08%
47,564 $2.08 Million
Q3 2018

Oct 04, 2018

SELL
$34.47 - $41.81 $1.75 Million - $2.13 Million
-50,893 Reduced 51.71%
47,524 $2.09 Million
Q2 2018

Jul 05, 2018

BUY
$32.98 - $35.16 $7,816 - $8,332
237 Added 0.24%
98,417 $3.57 Million
Q1 2018

Apr 16, 2018

BUY
$31.91 - $37.02 $62,639 - $72,670
1,963 Added 2.04%
98,180 $3.48 Million
Q4 2017

Jan 12, 2018

BUY
$33.26 - $35.29 $12,405 - $13,163
373 Added 0.39%
96,217 $3.49 Million
Q3 2017

Oct 10, 2017

BUY
$31.0 - $34.15 $2.97 Million - $3.27 Million
95,844
95,844 $3.42 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Insight Partners, LLC Portfolio

Follow Capital Insight Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.